VistaPharm, Inc. voluntarily recalled Phenytoin Oral Suspension USP 125mg/5mL on Oct. 15, 2013, after the FDA announced the product had defective containers causing out-of-specification assay and viscosity results. The recall affects 27,788 cases distributed nationwide and in Puerto Rico.
How to tell if you have it
- Brand: VistaPharm
- Product: Phenytoin Oral Suspension USP 125mg/5mL
- NDC: 66689-036-50
- Lots: 268200 (Exp 06/14), 274600 (Exp 08/14), 279500 (Exp 09/14), 290700 (Exp 12/14), 296700 (Exp 02/15), 305100 (Exp 06/15)
- Quantity: 50 cups per case
- Distribution: Nationwide and Puerto Rico
The hazard
The FDA said the recall is due to a lidding deformity in the containers that allowed for out-of-specification results for assay and viscosity at the 12-month stability timepoint.
Context
GovInfoNow's records show VistaPharm, Inc. has had 19 other recalls on record since Jan. 19, 2011. Other recent recalls of similar products include a Pyridostigmine Bromide Oral Solution recall for preservative issues (Sept. 30, 2022), a Clobazam Oral Suspension recall for failed stability specifications (Jan. 7, 2022), and a Nystatin Oral Suspension recall for impurity risk (Sept. 25, 2020).